Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended September 30, 2024

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ______________

Commission File Number: 001-41447

NeoVolta, Inc.

(Exact name of registrant as specified in its charter)

Nevada

82-5299263

(State or other jurisdiction

of incorporation)

(I.R.S. Employer

Identification No.)

13651 Danielson Street, Suite A

Poway, CA

92064

(Address of principal

executive offices)

(Zip code)

Registrant’s telephone number, including area code: (800) 364-5464

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol (s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	NEOV	The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock	NEOVW	The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒ No: ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒ No: ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☒		Smaller reporting company ☒
		Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

The number of shares outstanding of Common Stock, par value $0.001 per share, as of November 8, 2024, was 33,361,711 shares.

NEOVOLTA, INC.

FORM 10-Q

SEPTEMBER 30, 2024

INDEX

	Page

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS	3

PART I. FINANCIAL INFORMATION	4

Item 1. Financial Statements	4
Balance Sheets as of September 30, 2024 and June 30, 2024 (Unaudited)	4
Statements of Operations for the three months ended September 30, 2024 and 2023 (Unaudited)	5
Statements of Stockholders’ Equity for the three months ended September 30, 2024 and 2023 (Unaudited)	6
Statements of Cash Flows for the three months ended September 30, 2024 and 2023 (Unaudited)	7
Notes to Financial Statements (Unaudited)	8
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3. Quantitative and Qualitative Disclosures About Market Risk	17
Item 4. Controls and Procedures	17

PART II. OTHER INFORMATION	18

Item 1. Legal Proceedings	18
Item 1A. Risk Factors	18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	18
Item 3. Defaults Upon Senior Securities	18
Item 4. Mine Safety Disclosures	18
Item 5. Other Information	18
Item 6. Exhibits	19
Signatures	20

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report.

You should read the matters described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

All forward-looking statements speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

NEOVOLTA, INC.

Balance Sheets

(Unaudited)

	September 30,			June 30,
	2024			2024
Assets
Current assets:
Cash and cash equivalents	$	393,396		$	986,427
Accounts receivable, net		1,950,684			1,805,980
Inventory, net		1,767,624			1,787,308
Prepaid insurance and other current assets		38,406			76,815
Total current assets		4,150,110			4,656,530

Total assets	$	4,150,110		$	4,656,530

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	216,333		$	5,316
Accrued liabilities		37,442			55,784
Total current liabilities		253,775			61,100

Commitments and contingencies (Note 4)		–			–

Stockholders' equity:
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding		33,246			33,236
Additional paid-in capital		25,570,121			25,304,732
Accumulated deficit		(21,707,032	)		(20,742,538	)
Total stockholders' equity		3,896,335			4,595,430

Total liabilities and stockholders' equity	$	4,150,110		$	4,656,530

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Operations

(Unaudited)


	Three Months Ended
	September 30,
	2024			2023

Revenues from contracts with customers	$	590,236		$	764,130
Cost of goods sold		497,389			642,958
Gross profit		92,847			121,172

Operating expenses:
General and administrative		1,050,119			555,160
Research and development		8,617			–
Total operating expenses		1,058,736			555,160

Loss from operations		(965,889	)		(433,988	)

Other income:
Interest income		1,395			5,273
Total other income		1,395			5,273

Net loss	$	(964,494	)	$	(428,715	)

Weighted average shares outstanding - basic and diluted		33,244,061			33,155,127

Net loss per share - basic and diluted	$	(0.03	)	$	(0.01	)

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Stockholders' Equity

Three Months Ended September 30, 2024 and 2023

(Unaudited)

					Additional					Total
	Common Stock				Paid-in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Equity

Balance at June 30, 2024		33,236,091	$	33,236	$	25,304,732	$	(20,742,538	)	$	4,595,430

Stock compensation expense		9,776		10		265,389		–			265,399

Net loss		–		–		–		(964,494	)		(964,494	)

Balance at September 30, 2024		33,245,867	$	33,246	$	25,570,121	$	(21,707,032	)	$	3,896,335

					Additional					Total
	Common Stock				Paid-in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Equity

Balance at June 30, 2023		33,155,127	$	33,155	$	24,872,446	$	(18,439,228	)	$	6,466,373

Stock compensation expense		–		–		84,717		–			84,717

Net loss		–		–		–		(428,715	)		(428,715	)

Balance at September 30, 2023		33,155,127	$	33,155	$	24,957,163	$	(18,867,943	)	$	6,122,375

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Cash Flows

(Unaudited)


	Three Months Ended
	September 30,
	2024			2023
Cash flows from operating activities:
Net loss	$	(964,494	)	$	(428,715	)
Adjustments to reconcile net loss to net cash used in operations:
Stock compensation expense		265,399			84,717
Provision for expected credit losses/bad debt expense		85,250			110,000
Changes in current assets and liabilities
Accounts receivable		(229,954	)		(359,129	)
Inventory		19,684			353,349
Prepaid insurance and other current assets		38,409			50,803
Accounts payable		211,017			–
Accrued expenses		(18,342	)		9,886
Net cash flows used in operating activities		(593,031	)		(179,089	)

Net decrease in cash and cash equivalents		(593,031	)		(179,089	)

Cash and cash equivalents at beginning of period		986,427			2,002,789

Cash and cash equivalents at end of period	$	393,396		$	1,823,700

Supplemental disclosures of cash flow information
Cash paid for interest	$	–		$	–
Cash paid for income taxes	$	–		$	–

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Notes to Financial Statements

(Unaudited)

(1)

Business and Summary of Significant Accounting Policies

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $143,396.

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $90,000 as of September 30, 2024 and June 30, 2024:

Schedule of inventory	September 30, 2024		June 30, 2024

Raw materials, consisting of assembly parts, batteries and inverters	$	1,339,559	$	1,076,479
Work in progress		–		89,386
Finished goods		428,065		621,443

Total	$	1,767,624	$	1,787,308

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 37%, 26% and 13% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately 82% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately 47% and 19% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $1,020,000 and $1,030,000, respectively.

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of 2,693,775 shares as follows: (i) 1,348,181 shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (iii) 58,500 shares related to warrants issued to the underwriters in that same offering; (iv) 50,000 shares related to restricted stock units granted to an officer in March 2022; and (v) 115,844 shares issuable to directors and other advisors (see Notes 3 and 5).

Research and Development Costs – Research and development costs are expensed as incurred.

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.

As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.

(2)

Notes Payable

On September 3, 2024, we entered into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity on September 3, 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As a condition of receiving this line of credit from the lender, we have agreed not to issue any securities pursuant to the Company’s Form S-3 (file number 333-280400), without the lender’s consent, so long as any borrowings remain outstanding. As of September 30, 2024, we had made no borrowings under this credit agreement (see Note 5).

(3)

Equity

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate.

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

The following table presents activity with respect to the Company’s warrants for the three months ended September 30, 2024:

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at June 30, 2024

1,179,750

4.02

Warrants issued

–

Warrants exercised/forfeited

–

Outstanding at September 30, 2024

1,179,750

4.02

2.8

–

Exercisable at September 30, 2024

1,179,750

4.02

2.8

–

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

Stock Compensation Expense – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to 1,280,000 restricted stock units (“RSU’s”), with a grant date value of $2,854,000, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s on each anniversary in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each. However, no such additional grants have been made as of September 30, 2024.

In February 2022, we entered into a new employment agreement with our then CEO, effective April 1, 2022. As noted above, we engaged a new CEO effective April 29, 2024, replacing our former CEO who remains as Chairman of the Board and chief technology officer. Pursuant to the agreement, we issued our former CEO an RSU award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 had been achieved, however, Milestone 2 had not been achieved and was no longer achievable. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our former CEO as of January 1, 2023.

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO at a later date.

Based upon our assessment of the probability of our three executive officers noted above, plus a non-executive recipient of another RSU award issued in June 2024, ultimately achieving any applicable milestones specified under the RSU awards indicated above, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the three months ended September 30, 2024 and 2023 in the amounts of $221,524 and $40,842, respectively

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of September 30, 2024, we booked an accrual of $48,750 of compensation expense (of which $43,875 will be settled through the issuance of shares) for our three independent directors under this plan.

In the three months ended September 30, 2024, we recognized total non-cash stock compensation expense of $265,399 as follows: (i) $221,524 for the amortized value of the RSUs granted to our chief executive officer, as previously described, plus a non-executive recipient of another RSU award granted in June 2024; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were a total of 9,776 shares of our common stock that were issued to two grantees in the three months ended September 30, 2024, which were previously expensed in the year ended June 30, 2024.

In the three months ended September 30, 2023, we recognized total non-cash stock compensation expense of $84,717 as follows: (i) $40,842 for the amortized value of the RSUs granted to our two executive officers, as previously described; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were no shares of common stock that were issued to any grantees in the three months ended September 30, 2023.

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of September 30, 2024, we have made total awards of 1,992,623 shares under the Plan as follows: (i) 1,798,181 shares for the RSUs granted to our three executive officers and a non-executive recipient, as noted above; (ii) 153,808 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 40,634 shares granted to several wholesale dealers under an incentive sales program.

(4)

Commitments and Contingencies

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums, as determined annually on a calendar year basis.

We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results.

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

(5)

Subsequent Events

In October 2024, we issued a total of 115,844 shares of our common stock to certain Board members and various advisors, pursuant to annual contracts for their services. Included in this issuance were 98,844 shares attributable to our three independent directors and 17,000 shares attributable to various other advisors. We issued all of these shares to the recipients as consideration for their services rendered in the year ended June 30, 2024, and we have recognized the underlying expense for such services in the year ended June 30, 2024.

In October 2024, we also made a short-term loan in the amount of $250,000 to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide short term working capital to the customer in conjunction with the startup of the contract in Puerto Rico. This loan was largely funded by making a partial draw down on our recently obtained line of credit (see Note 2). Interest on the loan will accrue at the rate of 3% per annum on the unpaid balance, beginning January 1, 2025, and will increase to a rate of 6% per annum on the unpaid balance, beginning July 1, 2025, and will be payable monthly, beginning February 1, 2025. The principal and any unpaid interest will be payable in one year from the date of the loan.

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Introduction

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2024, filed with the Securities and Exchange Commission on September 27, 2024 (the “Annual Report”).

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

In addition, unless the context otherwise requires and for the purposes of this Report only:

“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;

“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and

“Securities Act” refers to the Securities Act of 1933, as amended.

Overview

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14, NV14-K, and NV-24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all our current resources and efforts go into further developing our flagship NV14, NV14-K, and NV-24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we have used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Utah, Colorado, Wyoming, Texas, Oklahoma, Missouri, Tennessee, Alabama, Georgia, Florida, and Puerto Rico.

As further discussed below under “Liquidity and Capital Resources,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

On April 14, 2023, California implemented Net Energy Metering 3 (NEM3) for subsequent new solar installations. NEM3 reduces the amount of NEM credit for each kilowatt (KW) of solar power sent to the utility from a rate of approximately $0.20 per KW to $0.09 per KW (each Utility varies). NEM3 effectively increases the average solar Return of Investment (ROI) from 5-6 years to 10-12 years (each Utility varies). Effectively, the Company believes that solar installation in California currently makes little financial sense without also including a battery system. Installing NeoVolta nets a ROI of 4-6 years. NEM3 reduced our sales from December 2022 until very recently as solar installers worked off their permitted NEM2 installs. We expect our sales to ultimately increase going forward.

Results of Operations

The following discussion reflects the Company’s revenues and expenses for the three month periods ended September 30, 2024 and 2023, as reported in our financial statements included in Item 1.

Revenues - Revenues from contracts with customers for the three months ended September 30, 2024 were $590,236 compared to $764,130 for the three months ended September 30, 2023. Such decrease was primarily due to the impact of various macroeconomic factors, such as relatively high interest rates, and regulatory factors, such as utility regulations in the State of California that we believe may have temporarily caused an economic disadvantage for residential utility customers to acquire our energy storage systems not only prior to the April 2023 effective date of those regulations, but also subsequently, as certain implications of them because better known in the marketplace.

Cost of Goods Sold - Cost of goods sold for the three months ended September 30, 2024 were $497,389 compared to $642,958 for the three months ended September 30, 2023. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 16% in both periods.

General and Administrative Expense - General and administrative expenses for the three months ended September 30, 2024 were $1,050,119 compared to $555,160 for the three months ended September 30, 2023. Such increase was mainly due to our engagement of a new chief executive officer, who was engaged at an annual salary of $350,000 and also received a 4 year amortizing equity award of $2,854,000, as well as several other employees since April 2024. The addition of these personnel resulted in a higher level of both cash compensation expense and other associated expenses, such as marketing and travel, as well as non-cash stock compensation expenses related to the Company’s equity incentive programs.

Research and Development Expense - Research and development expenses for the three months ended September 30, 2024 were $8,617 compared to zero for the three months ended September 30, 2023. Such fluctuation was largely due to timing differences in the level of the Company’s recent product development efforts.

Other Income and Expense - Interest income for the three months ended September 30, 2024 was $1,395 compared to $5,273 for the three months ended September 30, 2023. This decrease was due to the Company’s lower level of investable cash in the three months ended September 30, 2024.

Net Loss - Net loss for the three months ended September 30, 2024 was $964,494 compared to $428,715 for the three months ended September 30, 2023, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

Liquidity and Capital Resources

Operating activities. Net cash used in operating activities in the three months ended September 30, 2024 was $593,031 compared to $179,089 in the three months ended September 30, 2023. This increase was largely due to the current period increase in our comparative net loss, largely due to the decline in our gross profit and the increase in our other cash operating expenses. The fluctuations in our working capital components had only a de minimis impact on net operating cash flow on a comparative basis.

Financing activities. As indicated in Note 2, we entered into an agreement with a newly formed financing entity in September 2024 whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity in September 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As of September 30, 2024, we had made no borrowings under this credit agreement.

As of September 30, 2024, we had a cash balance of approximately $0.4 million and net working capital of approximately $3.9 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that, in conjunction with our recently obtained line of credit noted above, we will have sufficient cash to operate for at least the next 12 months.

Assembly Inventory Purchase

In April 2023, we made a bulk purchase of raw materials inventory from our contract manufacturer by making a cash payment to that company in the net amount of approximately $1.3 million. This transaction was completed pursuant to an amendment of our Master Supply Agreement with our contract manufacturer. In addition to the purchase of the raw materials inventory from our contract manufacturer, this amendment provided for the eventual assumption by us of full responsibility from our contract manufacturer for the manufacturing of our proprietary Energy Storage Systems (“ESS”) units. Pursuant to the amendment, we assumed such responsibility for the manufacturing process surrounding our ESS units from our contract manufacturer on June 1, 2023. In conjunction with assuming this responsibility, we hired the employees of our contract manufacturer who previously performed contract manufacturing services for us.

Other Developments

We continue to monitor current international developments occurring in Ukraine and Israel. However, we do not believe that they will have a significant impact on either the domestic markets for our products or the international supply chains for our product components, which are largely sourced from Asis.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024, for a further description of our critical accounting policies and estimates.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

As of September 30, 2024, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Changes in Internal Controls over Financial Reporting

There was no change in our internal controls over financial reporting that occurred during the quarter ended September 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

ITEM 1A.

RISK FACTORS

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024 (the “Form 10-K”), under the heading “Risk Factors”, and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2024, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There have been no sales of unregistered securities during the three months ended September 30, 2024.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION

During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

ITEM 6.

EXHIBITS

Exhibit No.		Exhibit Description
10.1		Line of Credit Agreement between NeoVolta, Inc. and National Energy Modelers, Inc., dated September 3, 2024 (incorporated by reference to exhibit 10.1 to the Company’s Form 8-K filed September 4, 2024)
31.1*		Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *		Inline XBRL Instance Document
101.SCH *		Inline XBRL Taxonomy Extension Schema Document
101.CAL *		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NEOVOLTA, INC.


November 8, 2024	/s/ H. Ardes Johnson
	H. Ardes Johnson
	Chief Executive Officer
	(Principal Executive Officer)

November 8, 2024	/s/ Steve Bond
	Steve Bond
	Chief Financial Officer
	(Principal Financial/Accounting Officer)

Exhibit 31.1

CERTIFICATION

I, H. Ardes Johnson, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2024

/s/ H. Ardes Johnson

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION

I, Steve Bond, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2024

/s/ Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, H. Ardes Johnson, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

/s/H. Ardes Johnson

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

November 8, 2024

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Bond, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

/s/Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

November 8, 2024

Cover - shares	3 Months Ended
Cover - shares	Sep. 30, 2024	Nov. 08, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--06-30
Entity File Number	001-41447
Entity Registrant Name	NeoVolta, Inc.
Entity Central Index Key	0001748137
Entity Tax Identification Number	82-5299263
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	13651 Danielson Street
Entity Address, Address Line Two	Suite A
Entity Address, City or Town	Poway
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92064
City Area Code	(800)
Local Phone Number	364-5464
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,361,711
Common Stock, par value $0.001 per share
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	NEOV
Security Exchange Name	NASDAQ
Warrants, each warrant exercisable for one share of common stock
Title of 12(b) Security	Warrants, each warrant exercisable for one share of common stock
Trading Symbol	NEOVW
Security Exchange Name	NASDAQ

Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents	$ 393,396	$ 986,427
Accounts receivable, net	1,950,684	1,805,980
Inventory, net	1,767,624	1,787,308
Prepaid insurance and other current assets	38,406	76,815
Total current assets	4,150,110	4,656,530
Total assets	4,150,110	4,656,530
Current liabilities:
Accounts payable	216,333	5,316
Accrued liabilities	37,442	55,784
Total current liabilities	253,775	61,100
Commitments and contingencies (Note 4)
Stockholders' equity:
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding	33,246	33,236
Additional paid-in capital	25,570,121	25,304,732
Accumulated deficit	(21,707,032)	(20,742,538)
Total stockholders' equity	3,896,335	4,595,430
Total liabilities and stockholders' equity	$ 4,150,110	$ 4,656,530

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2024	Jun. 30, 2024
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	33,245,867	33,236,091
Common Stock, Shares, Outstanding	33,245,867	33,236,091

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues from contracts with customers	$ 590,236	$ 764,130
Cost of goods sold	497,389	642,958
Gross profit	92,847	121,172
Operating expenses:
General and administrative	1,050,119	555,160
Research and development	8,617	0
Total operating expenses	1,058,736	555,160
Loss from operations	(965,889)	(433,988)
Other income:
Interest income	1,395	5,273
Total other income	1,395	5,273
Net loss	$ (964,494)	$ (428,715)

Statements of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Weighted Average Number of Shares Outstanding, Basic	33,244,061	33,155,127
Weighted Average Number of Shares Outstanding, Diluted	33,244,061	33,155,127
Earnings Per Share, Basic	$ (0.03)	$ (0.01)
Earnings Per Share, Diluted	$ (0.03)	$ (0.01)

Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2023	$ 33,155	$ 24,872,446	$ (18,439,228)	$ 6,466,373
Shares, Outstanding, Beginning Balance at Jun. 30, 2023	33,155,127
Stock compensation expense	$ 0	84,717	0	84,717
Net loss	0	0	(428,715)	(428,715)
Ending balance, value at Sep. 30, 2023	$ 33,155	24,957,163	(18,867,943)	6,122,375
Shares, Outstanding, Beginning Balance at Sep. 30, 2023	33,155,127
Beginning balance, value at Jun. 30, 2024	$ 33,236	25,304,732	(20,742,538)	4,595,430
Shares, Outstanding, Beginning Balance at Jun. 30, 2024	33,236,091
Stock compensation expense	$ 10	265,389	0	265,399
Stock issued for compensation, shares	9,776
Net loss	$ 0	0	(964,494)	(964,494)
Ending balance, value at Sep. 30, 2024	$ 33,246	$ 25,570,121	$ (21,707,032)	$ 3,896,335
Shares, Outstanding, Beginning Balance at Sep. 30, 2024	33,245,867

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (964,494)	$ (428,715)
Adjustments to reconcile net loss to net cash used in operations:
Stock compensation expense	265,399	84,717
Provision for expected credit losses/bad debt expense	85,250	110,000
Changes in current assets and liabilities
Accounts receivable	(229,954)	(359,129)
Inventory	19,684	353,349
Prepaid insurance and other current assets	38,409	50,803
Accounts payable	211,017	0
Accrued expenses	(18,342)	9,886
Net cash flows used in operating activities	(593,031)	(179,089)
Net decrease in cash and cash equivalents	(593,031)	(179,089)
Cash and cash equivalents at beginning of period	986,427	2,002,789
Cash and cash equivalents at end of period	393,396	1,823,700
Supplemental disclosures of cash flow information
Cash paid for interest
Cash paid for income taxes

Pay vs Performance Disclosure - USD ($)	3 Months Ended
Pay vs Performance Disclosure - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (964,494)	$ (428,715)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual [Table]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business and Summary of Significant Accounting Policies

3 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business and Summary of Significant Accounting Policies

(1)

Business and Summary of Significant Accounting Policies

Schedule of inventory	September 30, 2024		June 30, 2024

Raw materials, consisting of assembly parts, batteries and inverters	$	1,339,559	$	1,076,479
Work in progress		–		89,386
Finished goods		428,065		621,443

Total	$	1,767,624	$	1,787,308

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

Research and Development Costs – Research and development costs are expensed as incurred.

Notes Payable

3 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Notes Payable

(2)

Notes Payable

Equity

3 Months Ended

Sep. 30, 2024

Equity [Abstract]

Equity

(3)

Equity

The following table presents activity with respect to the Company’s warrants for the three months ended September 30, 2024:

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at June 30, 2024

1,179,750

4.02

Warrants issued

–

Warrants exercised/forfeited

–

Outstanding at September 30, 2024

1,179,750

4.02

2.8

–

Exercisable at September 30, 2024

1,179,750

4.02

2.8

–

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

(4)

Commitments and Contingencies

Subsequent Events

3 Months Ended

Sep. 30, 2024

Subsequent Events [Abstract]

Subsequent Events

(5)

Subsequent Events

Business and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Interim Financial Information

Cash and Cash Equivalents

Inventory

Schedule of inventory	September 30, 2024		June 30, 2024

Raw materials, consisting of assembly parts, batteries and inverters	$	1,339,559	$	1,076,479
Work in progress		–		89,386
Finished goods		428,065		621,443

Total	$	1,767,624	$	1,787,308

Revenue Recognition

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

Allowance for Expected Credit Losses

Stock Compensation Expense

Loss Per Common Share

Research and Development Costs

Research and Development Costs – Research and development costs are expensed as incurred.

Use of Estimates

Recent Accounting Pronouncements

Liquidity

Business and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of inventory

Schedule of inventory	September 30, 2024		June 30, 2024

Raw materials, consisting of assembly parts, batteries and inverters	$	1,339,559	$	1,076,479
Work in progress		–		89,386
Finished goods		428,065		621,443

Total	$	1,767,624	$	1,787,308

Equity (Tables)

3 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of warrant activity

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at June 30, 2024

1,179,750

4.02

Warrants issued

–

Warrants exercised/forfeited

–

Outstanding at September 30, 2024

1,179,750

4.02

2.8

–

Exercisable at September 30, 2024

1,179,750

4.02

2.8

–

Inventory (Details) - USD ($)	3 Months Ended
Inventory (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Raw materials, consisting of assembly parts, batteries and inverters	$ 1,339,559	$ 1,076,479
Work in progress	0	89,386
Finished goods	428,065	621,443
Total	1,767,624	1,787,308
Accounts Receivable, Allowance for Credit Loss	$ 1,020,000	$ 1,030,000
Antidilutive shares	2,693,775
Restricted Stock Units [Member] \| Officer And Another Employee [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Antidilutive shares	1,348,181
Restricted Stock Units [Member] \| An Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Antidilutive shares	50,000
Warrants [Member] \| Investors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Antidilutive shares	1,121,250
Warrants [Member] \| Underwriters [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Antidilutive shares	58,500
Common Stock [Member] \| Directors And Other Advisors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Antidilutive shares	115,844

Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Apr. 30, 2023
Product Information [Line Items]
Cash, Uninsured Amount	$ 143,396
Inventory, Gross				$ 1,400,000
Inventory reserve	$ 90,000		$ 90,000
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Dealer One [Member]
Product Information [Line Items]
Concentration Risk, Percentage	37.00%	47.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Dealer Two [Member]
Product Information [Line Items]
Concentration Risk, Percentage	26.00%	19.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Dealer Three [Member]
Product Information [Line Items]
Concentration Risk, Percentage	13.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Three Dealers [Member]
Product Information [Line Items]
Concentration Risk, Percentage	82.00%

Notes Payable (Details Narrative) - USD ($)	Sep. 03, 2024	Sep. 30, 2024
Debt Disclosure [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Line of credit interest rate	16.00%
Line of credit expiration date	Sep. 03, 2026
Line of credit, amount outstanding		$ 0

Equity (Details - Warrant activity)	3 Months Ended
Equity (Details - Warrant activity)	Sep. 30, 2024 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, ending	1,179,750
Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning	1,179,750
Warrants outstanding, weighted average exercise price, beginning \| $ / shares	$ 4.02
Warrants issued	0
Warrants issued, weighted average exercise price \| $ / shares	$ 0
Warrants exercised/forfeited	0
Warrants exercised/forfeited, weighted average exercise price \| $ / shares	$ 0
Warrants outstanding, ending	1,179,750
Warrants outstanding, weighted average exercise price, ending \| $ / shares	$ 4.02
Warrants outstanding, term	2 years 9 months 18 days
Warrants outstanding, aggregate intrinsic value \| $	$ 0
Warrants exercisable	1,179,750
Warrants exercisable, weighted average exercise price \| $ / shares	$ 4.02
Warrants exercisable, term	2 years 9 months 18 days
Warrants exercisable, aggregate intrinsic value \| $	$ 0

Equity (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		12 Months Ended		67 Months Ended
Equity (Details Narrative) - USD ($)	Apr. 30, 2024	Aug. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2022	Sep. 30, 2024	Jun. 30, 2024	Feb. 28, 2019
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			1,179,750				1,179,750
Warrants maturity date			Aug. 01, 2027				Aug. 01, 2027
Share based compensation			$ 265,399	$ 84,717
Accrued compensation			37,442				$ 37,442	$ 55,784
Non-cash stock compensation expense			265,399	84,717
Stock Plan 2019 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares authorized for issuance under plan									2,500,000
Shares granted							1,992,623
Amortized Value Of R S Us [Member]
Subsidiary, Sale of Stock [Line Items]
Non-cash stock compensation expense			221,524	40,842
Amortized Value Of Compensation Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Non-cash stock compensation expense			43,875	43,875
Chief Executive Officer [Member] \| Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period	1,280,000
Other than options, grant date fair value	$ 2,854,000
Former C E O [Member] \| Restricted Stock Units (RSUs) [Member] \| Milestone 1 [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period						50,000
Chief Financial Officer [Member] \| Restricted Stock Units (RSUs) [Member] \| Milestone 1 [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period						250,000
Chief Financial Officer [Member] \| Restricted Stock Units (RSUs) [Member] \| Milestone 2 [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period					50,000
Three Executive Officers And Non Executive [Member] \| Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Share based compensation			221,524	$ 40,842
Three Executive Officers And Non Executive [Member] \| Restricted Stock Units (RSUs) [Member] \| Stock Plan 2019 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares granted							1,798,181
Two Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Accrued compensation			$ 48,750				$ 48,750
Two Grantees [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period			9,776
Three Independent Directors [Member] \| Restricted Stock Units (RSUs) [Member] \| Stock Plan 2019 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares granted							153,808
Several Wholesale Dealers [Member] \| Restricted Stock Units (RSUs) [Member] \| Stock Plan 2019 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares granted							40,634
Underwritten Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Unit description		each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share.
Underwritten Public Offering [Member] \| Convertible Notes 2018 [Member]
Subsidiary, Sale of Stock [Line Items]
Debt converted, amount converted		$ 59,251
Debt converted, shares issued		9,404,867
Underwritten Public Offering [Member] \| Convertible Notes 2021 [Member]
Subsidiary, Sale of Stock [Line Items]
Debt converted, amount converted		$ 1,120,035
Debt converted, shares issued		267,000
Underwritten Public Offering [Member] \| Underwriter [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued, shares		58,500
Warrants issued, exercise price		$ 4.40
Underwritten Public Offering [Member] \| Units [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued new, shares		1,121,250
Gross proceeds from sale of equity		$ 4,485,000
Proceeds from sale of equity		$ 3,780,000

NeoVolta (NASDAQ:NEOVW)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Haga Click aquí para más Gráficas NeoVolta.

NeoVolta (NASDAQ:NEOVW)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

NEOVW NeoVolta Inc

Noticias sobre NeoVolta Inc NEOVW

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

NEOVW NeoVolta Inc

Noticias sobre NeoVolta Inc NEOVW

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación